Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 36,219 shares at $168.33 ($6.1M) on 2024-05-21, disclosed to the SEC on 2024-05-22.
Scheduled sale ($6.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.36 | 4,274 | $711K | 11.7% |
| 2 | $166.36 | 4,274 | $711K | 11.7% |
| 3 | $167.05 | 4,008 | $670K | 11.0% |
| 4 | $167.05 | 4,008 | $670K | 11.0% |
| 5 | $168.33 | 3,933 | $662K | 10.9% |
| 6 | $168.33 | 3,933 |
| $662K |
| 10.9% |
| 7 | $169.27 | 2,963 | $502K | 8.2% |
| 8 | $169.27 | 2,963 | $502K | 8.2% |
| 9 | $170.04 | 3,925 | $667K | 11.0% |
| 10 | $171.03 | 969 | $166K | 2.7% |
| 11 | $171.03 | 969 | $166K | 2.7% |
| Total | $168.07 avg | 36,219 | $6.1M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |